CW
AZN icon

CreativeOne Wealth’s AstraZeneca AZN Stock Holding History

CreativeOne Wealth’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,070
Closed -$471K – 1188
2025
Q3 		$471K Buy
3,070
+289
+10% +$43.7K 0.01% 791
2025
Q2 		$389K Buy
2,781
+92
+3% +$12.9K 0.01% 832
2025
Q1 		$395K Sell
2,689
-90
-3% -$13K 0.01% 769
2024
Q4 		$364K Buy
2,779
+1,423
+105% +$199K 0.01% 803
2024
Q3 		$211K Buy
+1,356
New +$219K 0.01% 889

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CreativeOne Wealth's AZN Position: Q4 2025 in Review

CreativeOne Wealth sold out of AstraZeneca (AZN) in Q4 2025, closing a stake of 3,070 shares — an estimated $471K sold.

CreativeOne Wealth first reported a position in AZN in Q3 2024 and held it in 5 quarters. The position peaked at $471K in Q3 2025. 1,405 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

  • CreativeOne Wealth reported no remaining AstraZeneca position as of Q4 2025 after selling out during the quarter.
  • CreativeOne Wealth sold 3,070 AstraZeneca shares in Q4 2025, an estimated $471K.
  • CreativeOne Wealth first reported a position in AstraZeneca in Q3 2024 and held it in 5 quarters.
  • CreativeOne Wealth's AstraZeneca position peaked at $471K in Q3 2025.
  • 1,405 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on CreativeOne Wealth's 13F filing for Q4 2025, filed 13 Feb 2026.